Pneumococcal serotype evolution in Western Europe

BMC Infectious Diseases

Table 3 Prevalence of PCV13 serotypes in Western European countries in older populations

	Age (year)	Post-PCV7 period		Three most prevalent serotypes	Post-higher valent PCV periods		Three most prevalent serotypes
	Age (year)	Year	Among all IPD, %	Three most prevalent serotypes	Year	Among all IPD, %	Three most prevalent serotypes
Countries in which only PCV13 used
France [18, 20]	≥65	2009	61	19A, 7 F, 3^a	2012	42	19A, 3, 7 F^a
Norway [25]	>5	2010	52	7 F, 19A, 1, 3	2012	45	7 F, 19A, 3
Switzerland [29]	>64	2010–11	66	3, 19A, 7 F	2012	62	3, 19A, 7 F
UK [31]	≥65	2008–10	54	19A, 3, 22 F	2013–14	21	8, 22 F, 3
Countries in which only PCV10 used
Austria [33, 37]	>50	2009	69	3, 6A, 14	2013	59	3, 14, 19A
Finland [39]	>65	2010	72	14, 3, 23 F	2014	60	3, 22 F, 19A
Netherlands [41]	All ages	2010	60	7 F, 8, 19A, 1	2013	45	8, 7 F, 19A
Countries in which both PCV13 and PCV10 used
Germany^a [42, 44]	>16	2008–2009	56	3, 7 F, 22 F^b	2012–2013	25	23B, 3, 7 F^c

ISSN: 1471-2334